Plasma procalcitonin in sepsis and organ failure

Annals of the Academy of Medicine Singapore

Volumn 30, Issue 5, 2001, Pages 528-531

  Yukioka, Hidekaza ^a   Yoshida, G ^b   Kurita, S ^b   Kato, N ^a  

^a Osaka Prefecture University   (Japan)

^b NONE

Author keywords

C reactive protein; Septic shock; SOFA score; Systemic inflammatory response syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; GLYCOPROTEIN; PROCALCITONIN; PROTEIN PRECURSOR;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOASSAY; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0035465111     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Póvoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragão A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24:1052-6.
2. Adamik B, Kübler-Kielb J, Golebiowoska B, Gamian A, Kübler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000; 26:1259-67.
3. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-8.
4. Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med 1999; 37:789-97.
5. Nijsten M W N, Olinga P, The T H, de Vries E G E, Koops H S, Groothuis G M M, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28:458-61.
6. Ugarte H, Silva E, Mercan D, Mendonça A D, Vincent J-L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27:498-504.
7. Müller B, Becker K L, Schächinger H, Rickenbacher P R, Huber P R, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28:977-83.
8. Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guérin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999; 18:875-81.
9. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
10. Vincent J-L, Moreno R, Takala J, Willatts S, DeMendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22: 707-10.
11. Dandona P, Nix D, Wilson M F, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subject. J Clin Endocrinol Metab 1994; 79:1605-8.
12. Oberhoffer M, Karzai W, Meier-Hellmann A, Bögel D, Fassbinder J, Reinhart K. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-α and interleukin-6 in patients with sepsis. Crit Care Med 1999; 27:1814-8.
13. Meisner M, Schmidt J, Hüttner H, Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000; 26:S212-6.
14. Brunkhorst F M, Wegscheider K, Forycki Z F, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26:S148-52.
15. von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N. Procalcitonin - a sepsis parameter in severe burn injuries. Burns 1998; 24:745-50.
16. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care (Lond) 1999; 3:45-55.
17. Nylen E S, Whang K T, Snider R H, Steinwald P M, White J C, Becker K L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26:1001-6.